Billionaire Stanley Druckenmiller is increasing his asset management firm’s exposure to a bet on the future of American healthcare.
Druckenmiller’s Duquesne Family Office boosted its stake in Natera Inc. (NTRA) by 4.19% in the third quarter of 2025.
[adinserter block="1"]The firm now holds 3,214,532 shares, valued at $517.4 million.
The position accounts for 12.74% of the $4.06 billion portfolio, making it the largest holding.
The increase added 129,342 shares, as reported in the firm’s latest 13F-HR filing with the SEC for the quarter ended September 30, 2025.
Druckenmiller initially bought the stock when Natera traded sideways from late 2022 to early 2023.
He added shares during a subsequent rally, took profits in Q1 and Q2 2025, and then bought the dip last quarter.
Natera specializes in non-invasive cell-free DNA testing for oncology, women’s health, and organ health.
The company reported 34.66% year-over-year revenue growth in Q3 2025, exceeding analyst estimates. Its stock has surged over 500% since bottoming in October 2023.
A number of analysts project Natera’s earnings per share to turn positive in 2028, with double-digit revenue growth expected through the next decade.
Follow us on X, Facebook and TelegramDon't Miss a Beat – Subscribe to get email alerts delivered directly to your inbox
Disclaimer: Opinions expressed at The Daily Hodl are not investment advice. Investors should do their due diligence before making any high-risk investments in Bitcoin, cryptocurrency or digital assets. Please be advised that your transfers and trades are at your own risk, and any losses you may incur are your responsibility. The Daily Hodl does not recommend the buying or selling of any assets including cryptocurrencies, nor is The Daily Hodl an investment advisor. Please note that The Daily Hodl participates in affiliate marketing.
Generated Image: Midjourney
